首页|腔内治疗急性肺栓塞的效果及对预后的影响

腔内治疗急性肺栓塞的效果及对预后的影响

扫码查看
目的:探究急性肺栓塞采取腔内治疗的效果及对凝血指标的影响.方法:选取2020年10月—2022 年 10 月在山东国欣颐养集团枣庄中心医院治疗的急性肺栓塞患者 92 例,应用随机数字表法将其分为对照组(n=46)及观察组(n=46).对照组接受静脉溶栓治疗,观察组接受腔内治疗.对比两组近期疗效、肺动脉高压、肺动脉开通情况(Miller指数)、炎症因子[C反应蛋白(CRP)、白细胞介素-6(IL-6)、肿瘤坏死因子-α(TNF-α)]、凝血功能指标[凝血酶原时间(PT)、活化部分凝血活酶时间(APTT)、纤维蛋白原(FIB)].结果:观察组治疗总有效率高于对照组,差异有统计学意义(P<0.05).治疗前,两组肺动脉高压、Miller指数相较,差异均无统计学意义(P>0.05);治疗后,两组肺动脉高压、Miller指数较治疗前均降低,且观察组均低于对照组(P<0.05).治疗前,两组CRP、IL-6、TNF-α比较,差异均无统计学意义(P>0.05);治疗后,两组CRP、IL-6、TNF-α较治疗前均降低,且观察组均低于对照组(P<0.05).治疗前,两组PT、APTT、FIB相较,差异均无统计学意义(P>0.05);治疗后,两组PT、APTT较治疗前均延长,FIB均降低,且观察组PT、APTT均长于对照组,FIB低于对照组(P<0.05).结论:急性肺栓塞患者采取腔内治疗,疗效显著,降低炎症反应,改善凝血功能.
The Effect of Intracavitary Treatment on Acute Pulmonary Embolism and Its Impact on Prognosis
Objective:To explore the effect of intracavitary treatment on acute pulmonary embolism and its impact on coagulation indicators.Method:A total of 92 patients with acute pulmonary embolism treated at Shandong Guoxin Yiyang Group Zaozhuang Central Hospital from October 2020 to October 2022 were selected,they were divided into a control group(n=46)and an observation group(n=46)by random number table method.The control group received intravenous thrombolysis treatment,while the observation group received intracavitary treatment.The recent therapeutic effects,pulmonary hypertension,pulmonary artery patency(Miller index),inflammatory cytokines[C reactive protein(CRP),interleukin-6(IL-6)and tumor necrosis factor-α(TNF-α)],coagulation function indicators[prothrombin time(PT),activated partial thromboplastin time(APTT),fibrinogen(FIB)]between two groups were compared.Result:The total effective rate of treatment in the observation group was higher than that in the control group,the difference was statistically significant(P<0.05).Before treatment,there were no statistically significant differences in pulmonary arterial hypertension and Miller index between the two groups(P>0.05);after treatment,pulmonary arterial hypertension and Miller index in both groups decreased compared to those before treatment,and those in the observation group were lower than those in the control group(P<0.05).Before treatment,there were no statistically significant differences in CRP,IL-6,TNF-α between the two groups,the differences were not statistically significant(P>0.05);after treatment,CRP,IL-6,TNF-α of two groups were decreased compared to those before treatment,and those in the observation group were lower than those in the control group(P<0.05).Before treatment,there were no statistically significant differences in PT,APTT and FIB between the two groups(P>0.05);after treatment,PT and APTT of two groups were prolonged compared to those before treatment,while FIB decreased,PT and APTT in the observation group were longer than those in the control group,and FIB was lower than that in the control group(P<0.05).Conclusion:Intraluminal treatment for acute pulmonary embolism patients has significant therapeutic effects,reduces inflammatory reactions,and improves coagulation function.

Acute pulmonary embolismIntracavitary therapyIntravenous thrombolytic therapyCoagulation index

陈德文、姚敏、周俊平

展开 >

山东国欣颐养集团枣庄中心医院呼吸内科 山东 枣庄 277000

山东国欣颐养集团枣庄医院感染疾病科 山东 枣庄 277000

急性肺栓塞 腔内治疗 静脉溶栓治疗 凝血指标

2024

中国医学创新
中国保健协会

中国医学创新

影响因子:1.706
ISSN:1674-4985
年,卷(期):2024.21(12)
  • 20